132 related articles for article (PubMed ID: 1100948)
1. Long-term follow-up of clofazimine (Lamprene) in the management of reactive phases of leprosy.
Karat AB
Lepr Rev; 1975 Jun; 46(2 Suppl):105-9. PubMed ID: 1100948
[No Abstract] [Full Text] [Related]
2. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
3. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
4. Clofazimine (lamprene or B663) in lepra reactions.
Imkamp FM
Lepr Rev; 1981 Jun; 52(2):135-40. PubMed ID: 7242222
[No Abstract] [Full Text] [Related]
5. Multicentre controlled comparative trial of clofazimine and dapsone in low dosages.
Ahrens TF; Pettit JH; Ridley DS; Glaus L
Lepr Rev; 1975 Dec; 46(4):287-96. PubMed ID: 1107728
[No Abstract] [Full Text] [Related]
6. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
Jamet P; Robin Y
Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
[TBL] [Abstract][Full Text] [Related]
7. Lamprene (clofazimine) in leprosy. Basic information.
Yawalkar SJ; Vischer W
Lepr Rev; 1979 Jun; 50(2):135-44. PubMed ID: 396428
[No Abstract] [Full Text] [Related]
8. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
Reyes-Javier PD; Tantiongco PR
Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
[No Abstract] [Full Text] [Related]
9. Lamprene (clofazimine) and its side effects.
Salafia A; Kharkar RD
Indian J Lepr; 1987; 59(3):313-4. PubMed ID: 3440850
[TBL] [Abstract][Full Text] [Related]
10. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
Karat AB
Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
[No Abstract] [Full Text] [Related]
11. The control of neuritis in leprosy with clofazimine.
Pfaltzgraff RE
Int J Lepr Other Mycobact Dis; 1972; 40(4):392-8. PubMed ID: 4586401
[No Abstract] [Full Text] [Related]
12. Clinical trial with clofazimine in leprosy.
Ganapati R; Dongre VV
Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
[TBL] [Abstract][Full Text] [Related]
13. The effect of long-term steroid therapy on patients treated with clofazimine (Lamprene).
Hogerzeil LM; Prabhudas N
Lepr Rev; 1975 Jun; 46(2 Suppl):111-5. PubMed ID: 1100949
[No Abstract] [Full Text] [Related]
14. Complications of treatment with clofazimine (Lamprene: B663).
Jopling WH
Lepr Rev; 1976 Mar; 47(1):1-3. PubMed ID: 1263731
[No Abstract] [Full Text] [Related]
15. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Levis WR; Spencer TI; Ladizinski B
J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
[No Abstract] [Full Text] [Related]
16. Clofazimine in the treatment of dapsone resistant leprosy.
Taylor PM; Alexander R
Lepr India; 1976 Oct; 48(4 Suppl):709-12. PubMed ID: 800234
[TBL] [Abstract][Full Text] [Related]
17. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy.
Hogerzeil LM
Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809
[TBL] [Abstract][Full Text] [Related]
18. A long term trial with clofazimine in reactive lepromatous leprosy.
Plock H; Leiker DL
Lepr Rev; 1976 Mar; 47(1):25-34. PubMed ID: 1263732
[No Abstract] [Full Text] [Related]
19. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Kumar B; Kaur S; Kaur I
Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
[TBL] [Abstract][Full Text] [Related]
20. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
Li WZ
Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
